Ascend Therapeutics Inc., of Herndon, Va., appointed the following people to its scientific advisory board: Carl Peck, Adrian Dobs, Rogerio Lobo, Robert Mansel, Russell Potts and Ronald Swerdloff.
Atrix Laboratories Inc., of Fort Collins, Colo., appointed Gregory Gould chief financial officer.
AusAm Biotechnologies Inc., of Santa Monica, Calif., appointed James Chambers to its board.
BioMarin Pharmaceutical Inc., of Novato, Calif., assembled a phenylketonuria advisory board consisting of Nenad Blau, Flemming Guttler, Richard Koch, Harvey Levy, Kimberlee Matalon, Reuben Matalon, Charles Scriver, Margretta Seashore, Raymond Stevens and Susan Waisbren.
BioMimetic Pharmaceuticals Inc., of Franklin, Tenn., appointed Larry Bullock chief financial officer and Charles Hart chief scientific officer and vice president of Orafacial Healthcare.
Bio-Reference Laboratories Inc., of Elmwood Park, N.J., appointed Harry Elias a member of its board.